Product NDC: | 55390-135 |
Proprietary Name: | Floxuridine |
Non Proprietary Name: | Floxuridine |
Active Ingredient(s): | 500 mg/5mL & nbsp; Floxuridine |
Administration Route(s): | INTRA-ARTERIAL |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-135 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075387 |
Marketing Category: | ANDA |
Start Marketing Date: | 20001016 |
Package NDC: | 55390-135-01 |
Package Description: | 1 VIAL in 1 BOX, UNIT-DOSE (55390-135-01) > 5 mL in 1 VIAL |
NDC Code | 55390-135-01 |
Proprietary Name | Floxuridine |
Package Description | 1 VIAL in 1 BOX, UNIT-DOSE (55390-135-01) > 5 mL in 1 VIAL |
Product NDC | 55390-135 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Floxuridine |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRA-ARTERIAL |
Start Marketing Date | 20001016 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | FLOXURIDINE |
Strength Number | 500 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Antimetabolite [EPC],Deoxyuridine [Chemical/Ingredient] |